Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
35.5M
-
Shares change
-
+35.5M
-
Total reported value, excl. options
-
$673M
-
Value change
-
+$673M
-
Number of buys
-
40
-
Price
-
$18.97
Significant Holders of Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share (THRD) as of Q3 2022
40 filings reported holding THRD - Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share (THRD) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.5M shares
of 45.1M outstanding shares and own 78.69% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10.9M shares), ORBIMED ADVISORS LLC (5.78M shares), BVF INC/IL (3.5M shares), RA CAPITAL MANAGEMENT, L.P. (3.48M shares), GENERAL ATLANTIC, L.P. (2.96M shares), Bain Capital Life Sciences Investors, LLC (2.28M shares), Deep Track Capital, LP (1.27M shares), WELLINGTON MANAGEMENT GROUP LLP (1.17M shares), COMMODORE CAPITAL LP (1.02M shares), and RTW INVESTMENTS, LP (610K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.